miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review

• Main Authors: Maria Teresa Di Martino (Author), Mariamena Arbitrio (Author), Daniele Caracciolo (Author), Alessia Cordua (Author), Onofrio Cuomo (Author), Katia Grillone (Author), Caterina Riillo (Author), Giulio Caridà (Author), Francesca Scionti (Author), Caterina Labanca (Author), Caterina Romeo (Author), Maria Anna Siciliano (Author), Maria D'Apolito (Author), Cristina Napoli (Author), Martina Montesano (Author), Valentina Farenza (Author), Valentina Uppolo (Author), Michele Tafuni (Author), Federica Falcone (Author), Giuseppe D'Aquino (Author), Natale Daniele Calandruccio (Author), Francesco Luciano (Author), Licia Pensabene (Author), Pierosandro Tagliaferri (Author), Pierfrancesco Tassone (Author)
• Format: Book
• Published: Elsevier, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence suggests miR-221 as a fine-tuner of chronic liver injury and inflammation-related events. Available information also supports...